Similarly, downregulation of miR-320 in estrogen receptor positive breast cancer cells results in Arpp19 overexpression and in the loss of tamoxifen sensitivity, a phenotype that is reversed by miR-320 restoration [108]. Here, ESR1 is linked to breast cancer.